NCT02858921 2023-08-30
Neo Trio
Melanoma Institute Australia
Phase 2 Unknown
Clinical Trials
5 trialsNCT05171374 2022-06-01
RATIONALE
MelanomaPRO, Russia
Unknown
NCT03754179 2021-04-28
COMBI-R2
Universitair Ziekenhuis Brussel
Phase 1/2 Unknown
NCT03088176 2020-10-12
Combining Talimogene Laherparepvec With BRAF and MEK Inhibitors in BRAF Mutated Advanced Melanoma
West Cancer Center
Phase 1 Unknown
NCT02625337 2017-09-15
IMPemBra
The Netherlands Cancer Institute
Phase 2 Unknown